These examples underscore how the integration of molecular diagnostics into clinical practice can optimize management, prevent unnecessary insulin use, and improve long-term outcomes in pediatric patients with monogenic diabetes [33, 34]. The gene discussed is INS; the disease is diabetes mellitus.